{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:35:37Z","timestamp":1759336537555,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.arteri.2021.02.010","type":"journal-article","created":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T03:59:48Z","timestamp":1617335988000},"page":"247-253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Hipercolesterolemia familiar en Gran Canaria: mutaci\u00f3n con efecto fundador y alta frecuencia de diabetes"],"prefix":"10.1016","volume":"33","author":[{"given":"Rosa M.","family":"S\u00e1nchez-Hern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana M.","family":"Gonz\u00e1lez-Lle\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Tugores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeray","family":"Brito-Casillas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Civeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Boronat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"W\u00e4gner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arteri.2021.02.010_bib0090","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/S0140-6736(69)90930-1","article-title":"Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states","volume":"2","author":"Slack","year":"1969","journal-title":"Lancet."},{"key":"10.1016\/j.arteri.2021.02.010_bib0095","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/HCO.0000000000000385","article-title":"Molecular basis of familial hypercholesterolemia","volume":"32","author":"Bruikman","year":"2017","journal-title":"Curr Opin Cardiol."},{"key":"10.1016\/j.arteri.2021.02.010_bib0100","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.atherosclerosis.2011.12.021","article-title":"Molecular characterization of familial hypercholesterolemia in Spain","volume":"221","author":"Palacios","year":"2012","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.arteri.2021.02.010_bib0105","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jacl.2019.04.099","article-title":"The island of Gran Canaria: A genetic isolate for familial hypercholesterolemia","volume":"13","author":"S\u00e1nchez-Hern\u00e1ndez","year":"2019","journal-title":"J Clin Lipidol."},{"key":"10.1016\/j.arteri.2021.02.010_bib0110","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1001\/jama.2015.1206","article-title":"Association between familial hypercholesterolemia and prevalence of type 2 diabetes mellitus","volume":"313","author":"Besseling","year":"2015","journal-title":"JAMA."},{"key":"10.1016\/j.arteri.2021.02.010_bib0115","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","article-title":"Statins and risk of incident diabetes: A collaborative meta-analysis of randomised statin trials","volume":"375","author":"Sattar","year":"2010","journal-title":"Lancet."},{"key":"10.1016\/j.arteri.2021.02.010_bib0120","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ijcard.2015.07.107","article-title":"Statins do not increase the risk of developing type 2 diabetes in familial hypercholesterolemia: The SAFEHEART study","volume":"201","author":"Fuentes","year":"2015","journal-title":"Int J Cardiol."},{"key":"10.1016\/j.arteri.2021.02.010_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-06101-6","article-title":"Effect of LDL cholesterol, statins and presence of mutations on the prevalence of type 2 diabetes in heterozygous familial hypercholesterolemia","volume":"7","author":"Climent","year":"2017","journal-title":"Sci Rep."},{"key":"10.1016\/j.arteri.2021.02.010_bib0130","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1177\/2047487319896138","article-title":"Behavioural cardiovascular risk factors and prevalence of diabetes in subjects with familial hypercholesterolaemia","volume":"27","author":"Perez-calahorra","year":"2020","journal-title":"Eur J Prev Cardiol."},{"key":"10.1016\/j.arteri.2021.02.010_bib0135","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1136\/jmedgenet-2016-104054","article-title":"The UCL low-density lipoprotein receptor gene variant database: Pathogenicity update","volume":"54","author":"Leigh","year":"2017","journal-title":"J Med Genet."},{"key":"10.1016\/j.arteri.2021.02.010_bib0140","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.atherosclerosis.2014.08.047","article-title":"Statin therapy and risk of diabetes in patients with heterozygous familial hypercholesterolemia or familial combined hyperlipidemia","volume":"237","author":"Skoumas","year":"2014","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.arteri.2021.02.010_bib0145","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s00125-011-2336-9","article-title":"Prevalence of diabetes mellitus and impaired glucose regulation in Spain: The Di@bet.es Study","volume":"55","author":"Soriguer","year":"2012","journal-title":"Diabetologia."},{"key":"10.1016\/j.arteri.2021.02.010_bib0150","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1464-5491.2005.01739.x","article-title":"Diabetes mellitus and impaired glucose regulation in the Canary Islands (Spain): Prevalence and associated factors in the adult population of Telde","volume":"23","author":"Boronat","year":"2006","journal-title":"Gran Canaria. Diabet Med."},{"key":"10.1016\/j.arteri.2021.02.010_bib0155","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.recesp.2019.08.005","article-title":"Clinical and genetic differences between heterozygous familial hypercholesterolemia patients with and without type 2 diabetes","volume":"73","author":"Climent","year":"2020","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.arteri.2021.02.010_bib0160","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.diabet.2017.04.010","article-title":"The impact of triglycerides on glucose tolerance: Lipotoxicity revisited","volume":"43","author":"Seghieri","year":"2017","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.arteri.2021.02.010_bib0165","doi-asserted-by":"crossref","first-page":"364","DOI":"10.2337\/dc17-1464","article-title":"Proprotein convertase subtilisin\/kexin type 9 (PCSK9) inhibitors and incident type 2 diabetes: A systematic review and meta-analysis with over 96,000 patient-Years","volume":"41","author":"De Carvalho","year":"2018","journal-title":"Diabetes Care."},{"key":"10.1016\/j.arteri.2021.02.010_bib0170","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/dmrr.2712","article-title":"Positive correlation of plasma PCSK9 levels with HbA1c in patients with type 2 diabetes","volume":"32","author":"Yang","year":"2016","journal-title":"Diabetes Metab Res Rev."}],"container-title":["Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0214916821000449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0214916821000449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:32:24Z","timestamp":1759325544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0214916821000449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0214916821000449"],"URL":"https:\/\/doi.org\/10.1016\/j.arteri.2021.02.010","relation":{},"ISSN":["0214-9168"],"issn-type":[{"type":"print","value":"0214-9168"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hipercolesterolemia familiar en Gran Canaria: mutaci\u00f3n con efecto fundador y alta frecuencia de diabetes","name":"articletitle","label":"Article Title"},{"value":"Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arteri.2021.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Sociedad Espa\u00f1ola de Arteriosclerosis. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}